This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukuda, T. Articles by Sekiguchi, K. Search for Related Content PubMed PubMed Citation Articles by Fukuda, T. Articles by Sekiguchi, K.

Mice Lacking the EDB Segment of Fibronectin Develop Normally but Exhibit Reduced Cell Growth and Fibronectin Matrix Assembly in Vitro¹

Institute for Protein Research [T. F., Y. M-H., K. S.] and Department of Orthopedic Surgery, Faculty of Medicine [M. S., K. K., N. Ya.], Osaka University, Suita, Osaka 565-0871; Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi, Osaka 594-1011 [T. F., N. Yo., Y. K., R. M., K. S.]; and Sekiguchi Biomatrix Signaling Project, Japan Science and Technology Corporation, Nagakute, Aichi 480-1195 [R. M., K. S.], Japan

Fibronectins (FNs) are major cell-adhesive proteins in the extracellular matrix and are essential for embryonic development. FNs are encoded by a single gene, but heterogeneity is introduced by alternative pre-mRNA splicing. One of the alternatively spliced segments, extra domain B (EDB), is prominently expressed during embryonic development and in tumor tissues, although it is mostly eliminated from FN in normal adult tissues. To examine the function of the EDB segment in vivo, we generated mice lacking the EDB exon using the Cre-loxP system. Although EDB-containing FNs are highly expressed throughout early embryogenesis, EDB-deficient mice developed normally and were fertile. Despite the absence of any significant phenotypes observed in vivo, however, fibroblasts obtained from EDB-deficient mice grew slowly in vitro and deposited less FN in the pericellular matrix than fibroblasts from wild-type mice. These results indicate that expression of EDB-containing isoforms is dispensable during embryonic development, yet may play a modulating role in the growth of connective tissue cells via the FN matrix.

This article has been cited by other articles:

				S. Sauer, P. A. Erba, M. Petrini, A. Menrad, L. Giovannoni, C. Grana, B. Hirsch, L. Zardi, G. Paganelli, G. Mariani, et al. Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients Blood, March 5, 2009; 113(10): 2265 - 2274. [Abstract] [Full Text] [PDF]

				A. V. Shinde, C. Bystroff, C. Wang, M. G. Vogelezang, P. A. Vincent, R. O. Hynes, and L. Van De Water Identification of the Peptide Sequences within the EIIIA (EDA) Segment of Fibronectin That Mediate Integrin {alpha}9{beta}1-dependent Cellular Activities J. Biol. Chem., February 1, 2008; 283(5): 2858 - 2870. [Abstract] [Full Text] [PDF]

				T. Moroy and F. Heyd The impact of alternative splicing in vivo: Mouse models show the way RNA, August 1, 2007; 13(8): 1155 - 1171. [Abstract] [Full Text] [PDF]

				A. Yoneda, D. Ushakov, H. A.B. Multhaupt, and J. R. Couchman Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -II Mol. Biol. Cell, January 1, 2007; 18(1): 66 - 75. [Abstract] [Full Text] [PDF]

				J. Matuskova, A. K. Chauhan, B. Cambien, S. Astrof, V. S. Dole, C. L. Piffath, R. O. Hynes, and D. D. Wagner Decreased Plasma Fibronectin Leads to Delayed Thrombus Growth in Injured Arterioles Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1391 - 1396. [Abstract] [Full Text] [PDF]

				E. Balza, L. Mortara, F. Sassi, S. Monteghirfo, B. Carnemolla, P. Castellani, D. Neri, R. S. Accolla, L. Zardi, and L. Borsi Targeted Delivery of Tumor Necrosis Factor-{alpha} to Tumor Vessels Induces a Therapeutic T Cell-Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin Clin. Cancer Res., April 15, 2006; 12(8): 2575 - 2582. [Abstract] [Full Text] [PDF]

				S. Astrof, D. Crowley, E. L. George, T. Fukuda, K. Sekiguchi, D. Hanahan, and R. O. Hynes Direct Test of Potential Roles of EIIIA and EIIIB Alternatively Spliced Segments of Fibronectin in Physiological and Tumor Angiogenesis Mol. Cell. Biol., October 1, 2004; 24(19): 8662 - 8670. [Abstract] [Full Text] [PDF]

				E. Bae, T. Sakai, and D. F. Mosher Assembly of Exogenous Fibronectin by Fibronectin-null Cells Is Dependent on the Adhesive Substrate J. Biol. Chem., August 20, 2004; 279(34): 35749 - 35759. [Abstract] [Full Text] [PDF]

				M. H. Tan, Z. Sun, S. L. Opitz, T. E. Schmidt, J. H. Peters, and E. L. George Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis Blood, July 1, 2004; 104(1): 11 - 18. [Abstract] [Full Text] [PDF]

				T. Kozaki, Y. Matsui, J. Gu, R. Nishiuchi, N. Sugiura, K. Kimata, K. Ozono, H. Yoshikawa, and K. Sekiguchi Recombinant Expression and Characterization of a Novel Fibronectin Isoform Expressed in Cartilaginous Tissues J. Biol. Chem., December 12, 2003; 278(50): 50546 - 50553. [Abstract] [Full Text] [PDF]

				A. F. Muro, A. K. Chauhan, S. Gajovic, A. Iaconcig, F. Porro, G. Stanta, and F. E. Baralle Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan J. Cell Biol., July 7, 2003; 162(1): 149 - 160. [Abstract] [Full Text] [PDF]